1-3 of 3
Sumita Trivedi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer

Raghvendra M. Srivastava, Sumita Trivedi, Fernando Concha-Benavente, Sandra P. Gibson, Carly Reeder, Soldano Ferrone, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (3): 707–716.
https://doi.org/10.1158/1078-0432.CCR-16-0879
Published: 31 January 2017
View article titled, CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer
Open the PDF for CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients

Sumita Trivedi, Raghvendra M. Srivastava, Fernando Concha-Benavente, Soldano Ferrone, Tatiana M. Garcia-Bates, Jing Li, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5229–5237.
https://doi.org/10.1158/1078-0432.CCR-15-2971
Published: 31 October 2016
View article titled, Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
Open the PDF for Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer

Patrick J. Schuler, Malgorzata Harasymczuk, Carmen Visus, Albert DeLeo, Sumita Trivedi, Yu Lei, Athanassios Argiris, William Gooding, Lisa H. Butterfield, Theresa L. Whiteside, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2433–2444.
https://doi.org/10.1158/1078-0432.CCR-13-2617
Published: 30 April 2014
View article titled, Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Open the PDF for Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer in another window
Includes: Supplementary data